Clinical Trial Update: Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacodynamics of SHR-1707 in patients with Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• SHR-1707

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED